A type of cell plentiful in the brain, long considered mainly the stuff that holds the brain together and oft-overlooked by scientists more interested in flashier cells known as neurons, wields more power in the brain than has been realized, according …
New research with monkeys sheds light on how the drug methylphenidate may affect learning and memory in children with attention deficit hyperactivity disorder. The results parallel a 1977 finding that a low dose of the drug boosted cognitive performanc…
In the U.S., in 2007, the prescription medication Vyvanse was introduced for the treatment of ADHD in children aged 6 to 12 years old by the US Food and Drug Administration (FDA). The following year the medication was approved to treat ADHD in adults, …
Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food and Drug Administration advised…
Adderall is a stimulant used to treat ADHD, but it’s also a controlled substance due to the addictive qualities of the drug. The DEA (Drug Enforcement Agency) monitors and controls how much of the base ingredients to manufacture the drug can be distrib…
Young and middle-aged adults who are prescribed ADHD (attention deficit/hyperactivity disorder) drugs do not have a higher chance of developing serious cardiovascular events, such as sudden cardiac death, heart attack or stroke, researchers from Kaiser…
Four gene variants, all members of the glutamate receptor gene family, appear to be involved in vital brain signaling pathways in a sub-set of children with ADHD (attention deficit hyperactivity disorder), researchers from the Center for Applied Genomi…
ADHD is usually thought of as a predominantly male problem, but a new report from Medco Health Solutions shows the number of women taking medication for ADHD is rising rapidly. Researchers studied trends in the use of mental health medications among ab…
A new report from the U.S. Department of Health and Human Services’ Agency for Healthcare Research and Quality (AHRQ) shows that formal training in parenting strategies is a low-risk, effective method for improving preschool-aged children’s behavior wh…
Shire plc presented positive top-level results of their first European phase III study of lisdexamfetamine dimesylate (LDX), designed for children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder (ADHD). LDX is adminis…
